Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS
· Delayed Price · Currency is USD
0.309
0.00 (0.00%)
At close: Dec 5, 2025
Lipella Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 0.39 | 0.54 | 0.45 | 0.18 | 0.26 | 0.96 | Upgrade
|
| Revenue Growth (YoY) | -19.39% | 19.29% | 144.15% | -28.99% | -73.03% | 38.42% | Upgrade
|
| Cost of Revenue | 3.57 | 3.61 | 3.04 | 2.55 | 1.46 | 0.98 | Upgrade
|
| Gross Profit | -3.18 | -3.08 | -2.59 | -2.36 | -1.2 | -0.01 | Upgrade
|
| Selling, General & Admin | 2.23 | 2 | 2.16 | 0.23 | 0.72 | 0.04 | Upgrade
|
| Operating Expenses | 2.23 | 2 | 2.16 | 0.23 | 0.72 | 0.04 | Upgrade
|
| Operating Income | -5.41 | -5.08 | -4.75 | -2.59 | -1.92 | -0.06 | Upgrade
|
| Interest Expense | - | - | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.08 | 0.06 | 0.14 | 0 | 0 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | -0 | 0 | - | Upgrade
|
| EBT Excluding Unusual Items | -5.33 | -5.02 | -4.62 | -2.6 | -1.92 | -0.06 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.06 | - | Upgrade
|
| Pretax Income | -5.33 | -5.02 | -4.62 | -2.6 | -1.87 | -0.06 | Upgrade
|
| Net Income | -5.33 | -5.02 | -4.62 | -2.6 | -1.87 | -0.06 | Upgrade
|
| Net Income to Common | -5.33 | -5.02 | -4.62 | -2.6 | -1.87 | -0.06 | Upgrade
|
| Shares Outstanding (Basic) | 3 | 1 | 1 | 1 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 1 | 1 | 1 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 217.27% | 39.69% | 47.84% | 19.15% | 59.91% | 2.46% | Upgrade
|
| EPS (Basic) | -1.75 | -4.79 | -6.16 | -5.12 | -4.38 | -0.23 | Upgrade
|
| EPS (Diluted) | -1.76 | -4.79 | -6.16 | -5.12 | -4.40 | -0.23 | Upgrade
|
| Free Cash Flow | -4.78 | -3.95 | -3.16 | -1.83 | -0.99 | -0.03 | Upgrade
|
| Free Cash Flow Per Share | -1.57 | -3.77 | -4.22 | -3.61 | -2.32 | -0.11 | Upgrade
|
| Gross Margin | - | - | - | - | - | -1.48% | Upgrade
|
| Operating Margin | -1387.94% | -947.23% | -1055.56% | -1406.26% | -738.71% | -5.91% | Upgrade
|
| Profit Margin | -1367.37% | -935.25% | -1027.31% | -1410.59% | -719.30% | -6.41% | Upgrade
|
| Free Cash Flow Margin | -1225.23% | -736.59% | -703.85% | -994.35% | -381.45% | -2.97% | Upgrade
|
| EBITDA | -5.41 | -5.08 | -4.74 | - | - | - | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0 | - | - | - | Upgrade
|
| EBIT | -5.41 | -5.08 | -4.75 | -2.59 | -1.92 | -0.06 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -5.91% | Upgrade
|
| Revenue as Reported | 0.39 | 0.54 | 0.45 | 0.18 | 0.26 | 0.96 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.